| |
| |
|
| Insider
Information: |
Marguglio David J. |
| Relationship: |
SVP and Chief Business... |
| City: |
Del Mar |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
233,906 |
|
|
Indirect Shares
|
5,884 |
|
|
| Direct
Value |
$8,421 |
|
|
|
Indirect Value
|
$212 |
|
|
| Total
Shares |
239,790 |
|
|
| Total
Value |
$8,632 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 123.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Adamis Pharmaceuticals Corp |
ADMP |
SVP and Chief Business... |
2022-03-18 |
233,906 |
2022-03-18 |
5,884 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADMP |
Adamis Pharmaceuticals Co... |
SVP and Chief Business Officer |
• • – |
2022-03-18 |
4 |
AS |
$0.60 |
$7,117 |
D/D |
(11,859) |
233,906 |
0 |
% |
|
| ADMP |
Adamis Pharmaceuticals Co... |
SVP and Chief Business Officer |
• • – |
2021-12-01 |
4 |
S |
$0.79 |
$39,844 |
D/D |
(50,757) |
258,765 |
0 |
% |
|
| ADMP |
Adamis Pharmaceuticals Co... |
SVP and Chief Business Officer |
• • – |
2021-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,258 |
309,522 |
0 |
- |
|
| ADMP |
Adamis Pharmaceuticals Co... |
SVP and Chief Business Officer |
• • – |
2020-11-20 |
4 |
S |
$0.40 |
$14,000 |
D/D |
(35,000) |
287,264 |
0 |
% |
|
| ADMP |
Adamis Pharmaceuticals Co... |
SVP and Chief Business Officer |
• • – |
2020-11-18 |
4 |
AS |
$0.41 |
$3,465 |
D/D |
(8,532) |
322,264 |
0 |
% |
|
| ADMP |
Adamis Pharmaceuticals Co... |
SVP and Chief Business Officer |
• • – |
2020-09-29 |
4 |
S |
$0.80 |
$16,000 |
D/D |
(20,000) |
308,539 |
0 |
% |
|
| ADMP |
Adamis Pharmaceuticals Co... |
SVP and Chief Business Officer |
• • – |
2020-08-18 |
4 |
AS |
$0.87 |
$7,648 |
D/D |
(8,749) |
328,539 |
0 |
% |
|
| ADMP |
Adamis Pharmaceuticals Co... |
SVP and Chief Business Officer |
• • – |
2020-05-18 |
4 |
AS |
$0.56 |
$4,332 |
D/D |
(7,734) |
337,288 |
0 |
% |
|
| ADMP |
Adamis Pharmaceuticals Co... |
SVP and Chief Business Officer |
• • – |
2020-03-18 |
4 |
AS |
$0.34 |
$3,479 |
D/D |
(10,337) |
325,022 |
0 |
% |
|
| ADMP |
Adamis Pharmaceuticals Co... |
SVP and Chief Business Officer |
• • – |
2020-02-24 |
4 |
AS |
$0.60 |
$6,004 |
D/D |
(9,948) |
335,359 |
0 |
% |
|
| ADMP |
Adamis Pharmaceuticals Co... |
SVP and Chief Business Officer |
• • – |
2019-11-18 |
4 |
AS |
$0.87 |
$7,197 |
D/D |
(8,283) |
365,307 |
0 |
- |
|
| ADMP |
Adamis Pharmaceuticals Co... |
SVP and Chief Business Officer |
• • – |
2019-08-19 |
4 |
AS |
$1.10 |
$8,883 |
D/D |
(8,109) |
373,590 |
0 |
- |
|
| ADMP |
Adamis Pharmaceuticals Co... |
SVP and Chief Business Officer |
• • – |
2019-05-20 |
4 |
AS |
$1.77 |
$15,464 |
D/D |
(8,735) |
381,699 |
0 |
- |
|
| ADMP |
Adamis Pharmaceuticals Co... |
SVP and Chief Business Officer |
• • – |
2019-03-20 |
4 |
S |
$2.28 |
$24,107 |
D/D |
(10,579) |
390,434 |
0 |
- |
|
| ADMP |
Adamis Pharmaceuticals Co... |
SVP and Chief Business Officer |
• • – |
2019-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,258 |
401,013 |
0 |
- |
|
| ADMP |
Adamis Pharmaceuticals Co... |
Sr VP of Business Development |
• • – |
2019-01-30 |
4 |
A |
$0.00 |
$0 |
D/D |
277,732 |
378,755 |
0 |
- |
|
| ADMP |
Adamis Pharmaceuticals Co... |
SR. VP of Corporate Devel. |
• • – |
2016-06-02 |
4 |
AS |
$9.00 |
$6,301 |
D/D |
(700) |
101,527 |
0 |
- |
|
| ADMP |
Adamis Pharmaceuticals Co... |
SR VP OF CORPORATE DEVELOPMENT |
• • – |
2016-05-16 |
4 |
AS |
$8.08 |
$32,339 |
D/D |
(4,000) |
102,227 |
0 |
- |
|
| ADMP |
Adamis Pharmaceuticals Co... |
SR VP OF CORPORATE DEVELOPMENT |
• • – |
2016-05-09 |
4/A |
AS |
$10.00 |
$60,000 |
D/D |
(6,000) |
106,227 |
0 |
- |
|
| ADMP |
Adamis Pharmaceuticals Co... |
SR VP of Corporate Development |
• • – |
2016-05-09 |
4 |
AS |
$10.00 |
$48,600 |
D/D |
(4,860) |
106,227 |
0 |
- |
|
| ADMP |
Adamis Pharmaceuticals Co... |
SR VP of Corporate Development |
• • – |
2016-05-04 |
4 |
AS |
$9.17 |
$44,577 |
D/D |
(4,860) |
112,227 |
0 |
- |
|
| ADMP |
Adamis Pharmaceuticals Co... |
SR VP of Corporate Development |
• • – |
2016-04-14 |
4 |
AS |
$7.52 |
$90,216 |
D/D |
(12,000) |
118,227 |
0 |
- |
|
| ADMP |
Adamis Pharmaceuticals Co... |
Senior Vice President |
• • – |
2015-12-30 |
5 |
GD |
$0.00 |
$0 |
D/D |
9,000 |
130,227 |
0 |
- |
|
| ADMP |
Adamis Pharmaceuticals Co... |
Sr VP of Business Development |
• • – |
2015-04-20 |
4 |
AS |
$5.00 |
$1,000 |
D/D |
(200) |
140,323 |
0 |
- |
|
| ADMP |
Adamis Pharmaceuticals Co... |
Sr VP of Business Development |
• • – |
2015-04-17 |
4 |
AS |
$5.01 |
$501 |
D/D |
(100) |
140,523 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
